XML 121 R102.htm IDEA: XBRL DOCUMENT v3.23.1
Related Parties - Restricted Stock Program (Detail)
R$ / shares in Units, R$ in Thousands
 12 Months Ended
Dec. 31, 2022
BRL (R$)
shares
R$ / shares
Disclosure of transactions between related parties [line items]  
Number of shares granted (Quantity) | shares 8,934,704
Total exercisable grant costs, including taxes R$ 244,295
Accumulated recognized exercisable grant costs (64,523)
Accumulated unrecognized exercisable grant costs R$ 179,772
Restricted Stock Award [Member] | Grant Date, April 4, 2018 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 4, 2018
Number of shares granted (Quantity) | shares 6,658
Vesting period 2023
Market price of shares on the grant date | R$ / shares R$ 34.35
Total exercisable grant costs, including taxes R$ 427
Accumulated recognized exercisable grant costs (406)
Accumulated unrecognized exercisable grant costs R$ 21
Restricted Stock Award [Member] | Grant Date, September 19, 2018 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 19, 2018
Number of shares granted (Quantity) | shares 80,000
Vesting period 2024
Market price of shares on the grant date | R$ / shares R$ 19.58
Total exercisable grant costs, including taxes R$ 2,675
Accumulated recognized exercisable grant costs (1,895)
Accumulated unrecognized exercisable grant costs R$ 780
Restricted Stock Award [Member] | Grant Date, September 24, 2018 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 24, 2018
Number of shares granted (Quantity) | shares 80,000
Vesting period 2024
Market price of shares on the grant date | R$ / shares R$ 18.4
Total exercisable grant costs, including taxes R$ 2,528
Accumulated recognized exercisable grant costs (1,791)
Accumulated unrecognized exercisable grant costs R$ 737
Restricted Stock Award [Member] | Grant Date, April 3, 2019 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 3, 2019
Number of shares granted (Quantity) | shares 74,916
Vesting period 2023 and 2024
Market price of shares on the grant date | R$ / shares R$ 23.25
Total exercisable grant costs, including taxes R$ 3,264
Accumulated recognized exercisable grant costs (2,758)
Accumulated unrecognized exercisable grant costs R$ 506
Restricted Stock Award [Member] | Grant Date, September 2, 2019 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 2, 2019
Number of shares granted (Quantity) | shares 320,000
Vesting period 2025
Market price of shares on the grant date | R$ / shares R$ 16.42
Total exercisable grant costs, including taxes R$ 9,013
Accumulated recognized exercisable grant costs (5,007)
Accumulated unrecognized exercisable grant costs R$ 4,006
Restricted Stock Award [Member] | Grant Date, April 1, 2020 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 1, 2020
Number of shares granted (Quantity) | shares 182,853
Vesting period 2023 to 2025
Market price of shares on the grant date | R$ / shares R$ 12.53
Total exercisable grant costs, including taxes R$ 4,267
Accumulated recognized exercisable grant costs (3,064)
Accumulated unrecognized exercisable grant costs R$ 1,203
Restricted Stock Award [Member] | Grant Date, September 16, 2020 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 16, 2020
Number of shares granted (Quantity) | shares 300,000
Vesting period 2026
Market price of shares on the grant date | R$ / shares R$ 23.03
Total exercisable grant costs, including taxes R$ 11,793
Accumulated recognized exercisable grant costs (4,586)
Accumulated unrecognized exercisable grant costs R$ 7,207
Restricted Stock Award [Member] | Grant Date, April 7, 2021 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 7, 2021
Number of shares granted (Quantity) | shares 425,422
Vesting period 2024
Market price of shares on the grant date | R$ / shares R$ 21
Total exercisable grant costs, including taxes R$ 16,705
Accumulated recognized exercisable grant costs (9,744)
Accumulated unrecognized exercisable grant costs R$ 6,961
Restricted Stock Award [Member] | Grant Date, September 22, 2021 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 22, 2021
Number of shares granted (Quantity) | shares 1,000,000
Vesting period 2027
Market price of shares on the grant date | R$ / shares R$ 14.17
Total exercisable grant costs, including taxes R$ 24,363
Accumulated recognized exercisable grant costs (5,543)
Accumulated unrecognized exercisable grant costs R$ 18,820
Restricted Stock Award [Member] | Grant Date, April 6, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 6, 2022
Number of shares granted (Quantity) | shares 777,065
Vesting period 2025
Market price of shares on the grant date | R$ / shares R$ 14.16
Total exercisable grant costs, including taxes R$ 20,573
Accumulated recognized exercisable grant costs (5,143)
Accumulated unrecognized exercisable grant costs R$ 15,430
Restricted Stock Award [Member] | Grant Date, September 21, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 21, 2022
Number of shares granted (Quantity) | shares 2,640,000
Vesting period 2032
Market price of shares on the grant date | R$ / shares R$ 12.98
Total exercisable grant costs, including taxes R$ 64,048
Accumulated recognized exercisable grant costs (2,135)
Accumulated unrecognized exercisable grant costs R$ 61,913
Restricted Stock Award [Member] | Grant Date, December 7, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date December 7, 2022
Number of shares granted (Quantity) | shares 1,500,000
Vesting period 2032
Market price of shares on the grant date | R$ / shares R$ 13.47
Total exercisable grant costs, including taxes R$ 38,125
Accumulated recognized exercisable grant costs (318)
Accumulated unrecognized exercisable grant costs R$ 37,807
Performance Stock Award [Member] | Grant Date, April 3, 2019 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 3, 2019
Number of shares granted (Quantity) | shares 37,458
Vesting period 2024
Market price of shares on the grant date | R$ / shares R$ 23.25
Total exercisable grant costs, including taxes R$ 1,619
Accumulated recognized exercisable grant costs (1,214)
Accumulated unrecognized exercisable grant costs R$ 405
Performance Stock Award [Member] | Grant Date, April 1, 2020 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 1, 2020
Number of shares granted (Quantity) | shares 276,580
Vesting period 2023 to 2025
Market price of shares on the grant date | R$ / shares R$ 12.53
Total exercisable grant costs, including taxes R$ 6,440
Accumulated recognized exercisable grant costs (4,854)
Accumulated unrecognized exercisable grant costs R$ 1,586
Performance Stock Award [Member] | Grant Date, April 7, 2021 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 7, 2021
Number of shares granted (Quantity) | shares 454,520
Vesting period 2024
Market price of shares on the grant date | R$ / shares R$ 21
Total exercisable grant costs, including taxes R$ 17,824
Accumulated recognized exercisable grant costs (10,864)
Accumulated unrecognized exercisable grant costs R$ 6,960
Performance Stock Award [Member] | Grant Date, April 6, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 6, 2022
Number of shares granted (Quantity) | shares 779,232
Vesting period 2025
Market price of shares on the grant date | R$ / shares R$ 14.16
Total exercisable grant costs, including taxes R$ 20,631
Accumulated recognized exercisable grant costs (5,201)
Accumulated unrecognized exercisable grant costs R$ 15,430